Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1183867
Name of medicinal product: ATACAND
Active substances:
Estonian, English, Latin
ATC code: C09CA06
Dosage form: tablet
Route of administration: oral use
Strengh: 32mg
Amount in package: 28TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Atacand is indicated for: ? The treatment of primary hypertension in adults. ? The treatment of hypertension in children and adolescents aged 6 to <18 years. ? The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ? 40%) when Angiotensin Converting Enzyme (ACE)- inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).
Safety features: Yes
Summary of product characteristics (SPC):  (last updated November 15, 2023)
Package information leaflet (PIL): EST  (last updated December 11, 2023)
Labelling:  (last updated November 15, 2023)
Last imported to Estonia: September 15, 2023
Marketing authorization holder: Cheplapharm Arzneimittel GmbH 
Marketing authorization number: 511306 
Marketing authorization issued on: March 30, 2006 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
90  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No  4 years - 17 years   
75  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No      
50  01.01.2024     Yes      No      
90  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No      
100  01.01.2024     Yes      No  until 4 years   
90  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No      
90  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No  from 63 years   
100  01.01.2024     Yes  I15-I15; I50-I50; I10-I13    No  until 4 years   
Reference price: 7,84 EUR 
Under reference price: No 
Reference price of daily dose: 0,07 EUR 
Description Additional condition
Perearsti õel on õigus välja kirjutada Välja arvatud esmane retsept
Entry/Changing date: December 11, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere